Value-based care is an approach to healthcare that aims to improve the quality of care and outcomes, reduce costs, and boost overall population health. But since “value-based care” is often bandied about as a buzzword to entice and comfort patients without really being implemented, we’re shining a spotlight on a few value-based care companies who are making strides to take VBC from a lofty ideal to an executable operating model.
Sickbay: This patient monitoring platform from Medical Informatics Corporation uses AI to capture data in near real-time from biomedical devices connected to a patient and just as quickly analyzes the information to push out alerts to physicians and other healthcare providers to reduce patient risk. Early interventions that might be prompted here are a backbone of value-based care, allowing physicians to understand the progression of an ailment more fully at its preliminary stages.
Lemonaid: With access to a team of doctors licensed in every state at your fingertips, Lemonaid allows users access to top-of-the-range healthcare from the comfort of their homes. They will diagnose and recommend treatment or prescribe medication for a vast range of both physical and mental health disorders. Not only does Lemonaid provide users with a diagnosis and prescription, they also offer a quick, discreet and affordable medicine delivery service.
SteadyMD: SteadyMD is like having a direct line to your doctor that you can use whenever you want. It’s a telehealth service, which means you can see a doctor over the phone or via your computer. They provide personalized medical care that’s ongoing and continuous, with the same doctor every time. Chat, call, or video chat with your doctor whenever you need them and get treatment and preventative care right away.
Digital Diagnostics: This is the first company to ever receive FDA clearance for an AI diagnostic platform that makes a diagnosis without physician input. Digital Diagnostics has diligently worked from within the healthcare system to establish automated diagnosis as the new standard of care. From real-world clinic launch & EMR integration, to the creation of the first ever autonomous AI CPT® category 1 code for billing and payment, to inclusion in the American Diabetes Association (ADA)’s 2020 Standards of Care in Diabetes, Digital Diagnostics has proven that intelligent diagnostic platforms can be deployed safely and responsibly to improve patient outcomes and increase healthcare productivity. Digital Diagnostics is in use at over 20 health systems and their customers have tested thousands of patients and identified hundreds of patients with disease who were previously undiagnosed. Additionally, Digital Diagnostics just launched additional AI platforms for the detection of a wide range of disease states beyond the eye.
While these companies are certainly part of the value-based care vanguard, there is still a long way to go in terms of disrupting the entrenched fee-for-service model under which most of the healthcare industry operates. It will take steps such as payers meaningfully incentivizing preventative care, technology firms creating new modes of service, and providers restructuring how they provide care.
When anesthesia groups partner with surgeons operating outside the hospital, the real value offered to surgeons is how the anesthesia group can (and should!) become a holistic part of the team. It means the “outsourced” nature of the relationship is, up front, about relieving costs and workflow abrasion for surgeons. However, the anesthesia group should...
Last week, we discussed the exit from retail primary care by Amazon, Berkshire Hathaway, and Wal-Mart, and the challenges they faced in entering healthcare, particularly primary care and clinic spaces. Today, we want to talk about other paths that future investors can take to drive change, even working hand-in-hand with existing entities, helping all parties...
Retail healthcare was poised to be a major disruptor. Unfortunately, in the past few months, Amazon, Berkshire Hathaway, and Walmart have all exited clinic and primary care spaces. While their entrance was a controversial choice, the undercurrent was hopeful. The quintuple aim’s goals are, in part, to improve access to care and improve quality of...
Join the thousands of medical industry insiders getting news and insights delivered straight to their inbox weekly